Last reviewed · How we verify
Recurrent genital herpes simplex
Approved treatments
- Famvir · Novartis
Famvir works by inhibiting the replication of herpes simplex virus DNA through its action as a nucleoside analog DNA polymerase inhibitor. - Aciclovir · Assistance Publique Hopitaux De Marseille
- Zovirax · Ligand Pharms
Acyclovir works by mimicking a building block of DNA to prevent the herpes virus from replicating. - Valtrex · GSK
Valtrex works by inhibiting the replication of herpes simplex virus DNA through interference with viral DNA polymerase. - ACYC · Ligand Pharms
Acyc works by binding to a specific target in the body, although its exact mechanism is unknown.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Recurrent genital herpes simplex patent landscape — cliff calendar, originator estates, attackable patents
- Recurrent genital herpes simplex treatment landscape brief
- Recurrent genital herpes simplex treatment updates RSS
Frequently asked questions about Recurrent genital herpes simplex
What drugs treat Recurrent genital herpes simplex?
Tracked treatments include Famvir, Aciclovir, Zovirax, Valtrex, ACYC.
What is the treatment for Recurrent genital herpes simplex?
Standard treatment for Recurrent genital herpes simplex includes Famvir, Aciclovir, Zovirax, Valtrex, ACYC. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Recurrent genital herpes simplex patent cliff · Recurrent genital herpes simplex CI report
- Treatment: Famvir · Novartis
- Treatment: Aciclovir · Assistance Publique Hopitaux De Marseille
- Treatment: Zovirax · Ligand Pharms
- Treatment: Valtrex · GSK
- Treatment: ACYC · Ligand Pharms
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing